Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 Nov;42(2):247–254.

IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA.

M L Trascasa, J Egido, J Sancho, L Hernando
PMCID: PMC1537109  PMID: 6781799

Abstract

Eleven out of 15 patients with IgA mesangial glomerulonephritis (Berger's disease) had an increased proportion of serum IgA in 9-21S fractions on 5-40% sucrose density-gradient ultracentrifugation; the heavier fractions decreased at acid pH. Serum IgA purified by starch electrophoresis was subjected to reduction-alkylation yielding fragments of lower molecular weight. J chain was detected on urea alkaline polyacrylamide electrophoresis and the high-molecular weight IgA bound the human secretory component. In six patients treated with phenytoin for 1 year there was a decrease in polymeric IgA and an increase in monomeric IgA adopting a pattern similar to that of the controls. Our results show the presence of a large amount of true IgA polymers, partially as immune complexes, in the serum of patients with Berger's disease. These data together with their normalization after phenytoin treatment may open a new pathogenic and therapeutic approach to this entity.

Full text

PDF
254

Images in this article

251Fig. 2
on p.251

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger J., Hinglais N. Les ddpôts intercapillaires d'IgA-IgG. J Urol Nephrol (Paris) 1968 Sep;74(9):694–695. [PubMed] [Google Scholar]
  2. Berger J. IgA glomerular deposits in renal disease. Transplant Proc. 1969 Dec;1(4):939–944. [PubMed] [Google Scholar]
  3. Berger J., Yaneva H., Nabarra B., Barbanel C. Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int. 1975 Apr;7(4):232–241. doi: 10.1038/ki.1975.35. [DOI] [PubMed] [Google Scholar]
  4. Brandtzaeg P. Characteristics of SC-Ig complexes formed in vitro. Adv Exp Med Biol. 1974;45(0):87–97. doi: 10.1007/978-1-4613-4550-3_10. [DOI] [PubMed] [Google Scholar]
  5. Dobrin R. S., Knudson F. E., Michael A. F. The secretory immune system and renal disease. Clin Exp Immunol. 1975 Aug;21(2):318–328. [PMC free article] [PubMed] [Google Scholar]
  6. Gavrilova E. M., Egorov A. M., Shakhanina K. L. Vydelenie i immunokhimicheskoe izuchenie monomernoi i dimernoi form IgA globulinov cheloveka. Biokhimiia. 1976 Apr;41(4):684–691. [PubMed] [Google Scholar]
  7. Germuth F. G., Jr, Rodriguez E. Focal mesangiopathic glomerulonephritis: prevalence and pathogenesis. Kidney Int. 1975 Apr;7(4):216–223. doi: 10.1038/ki.1975.33. [DOI] [PubMed] [Google Scholar]
  8. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  9. Lagrue G., Hirbec G., Fournel M., Intrator L. Glomérulonéphrite mésangiale à dépôts d'IgA étude des immunoglobulines sériques. J Urol Nephrol (Paris) 1974 Apr-May;80(4-5):385–392. [PubMed] [Google Scholar]
  10. Lowance D. C., Mullins J. D., McPhaul J. J., Jr Immunoglobulin A (IgA) associated glomerulonephritis. Kidney Int. 1973 Mar;3(3):167–176. doi: 10.1038/ki.1973.25. [DOI] [PubMed] [Google Scholar]
  11. McCoy R. C., Abramowsky C. R., Tisher C. C. IgA nephropathy. Am J Pathol. 1974 Jul;76(1):123–144. [PMC free article] [PubMed] [Google Scholar]
  12. Nomoto Y., Sakai H., Arimori S. Increase of IgA-bearing lymphocytes in peripheral blood from patients with IgA nephropathy. Am J Clin Pathol. 1979 Feb;71(2):158–160. doi: 10.1093/ajcp/71.2.158. [DOI] [PubMed] [Google Scholar]
  13. Reisfeld R. A., Small P. A., Jr Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science. 1966 May 27;152(3726):1253–1255. doi: 10.1126/science.152.3726.1253. [DOI] [PubMed] [Google Scholar]
  14. Rifai A., Small P. A., Jr, Teague P. O., Ayoub E. M. Experimental IgA nephropathy. J Exp Med. 1979 Nov 1;150(5):1161–1173. doi: 10.1084/jem.150.5.1161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sakai H., Nomoto Y., Arimori S. Decrease of IgA-specific suppressor T cell activity in patients with IgA nephropathy. Clin Exp Immunol. 1979 Nov;38(2):243–248. [PMC free article] [PubMed] [Google Scholar]
  16. Seager J., Jamison D. L., Wilson J., Hayward A. R., Soothill J. F. IgA deficiency, epilepsy, and phenytoin treatment. Lancet. 1975 Oct 4;2(7936):632–635. doi: 10.1016/s0140-6736(75)90115-4. [DOI] [PubMed] [Google Scholar]
  17. Tung K. S., Woodroffe A. J., Ahlin T. D., Williams R. C., Jr, Wilson C. B. Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis. J Clin Invest. 1978 Jul;62(1):61–72. doi: 10.1172/JCI109115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Underdown B. J., DeRose J., Koczekan K., Socken D., Weicker J. Isolation of human secretory component by affinity chromatography on IgM-sepharose. Immunochemistry. 1977 Feb;14(2):111–118. doi: 10.1016/0019-2791(77)90289-0. [DOI] [PubMed] [Google Scholar]
  19. Van Epps D. E., Williams R. C., Jr Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med. 1976 Nov 2;144(5):1227–1242. doi: 10.1084/jem.144.5.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Whitworth J. A., Leibowitz S., Kennedy M. C., Cameron J. S., Chantler C. IgA and glomerular disease. Clin Nephrol. 1976 Jan;5(1):33–36. [PubMed] [Google Scholar]
  21. van der Peet J., Arisz L., Brentjens J. R., Marrink J., Hoedemaeker P. J. The clinical course of IgA nephropathy in adults. Clin Nephrol. 1977 Aug;8(2):335–340. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES